Literature DB >> 27642158

A case of refractory dermatomyositis responsive to tofacitinib.

Julie J Paik1, Lisa Christopher-Stine2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27642158     DOI： 10.1016/j.semarthrit.2016.08.009

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN： 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  15 in total

Review 1.  JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Authors:  Daniella M Schwartz; Yuka Kanno; Alejandro Villarino; Michael Ward; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Drug Discov       Date:  2017-11-06       Impact factor: 84.694

2.  JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Authors:  Daniella M Schwartz; Yuka Kanno; Alejandro Villarino; Michael Ward; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Drug Discov       Date:  2017-12-28       Impact factor: 84.694

Review 3.  Treatment in myositis.

Authors:  Chester V Oddis; Rohit Aggarwal
Journal:  Nat Rev Rheumatol       Date:  2018-03-29       Impact factor: 20.543

4.  [Response of dermatomyositis with lung involvement to Janus kinase inhibitor treatment].

Authors:  J Hornig; T Weinhage; L H Schmidt; B Buerke; U Schneider; H Pavenstädt; H Becker; G Gabriëls
Journal:  Z Rheumatol       Date:  2018-12       Impact factor: 1.372

Review 5.  JAK inhibitors in dermatology: The promise of a new drug class.

Authors:  William Damsky; Brett A King
Journal:  J Am Acad Dermatol       Date:  2017-01-28       Impact factor: 11.527

6.  Identification of distinctive interferon gene signatures in different types of myositis.

Authors:  Iago Pinal-Fernandez; Maria Casal-Dominguez; Assia Derfoul; Katherine Pak; Paul Plotz; Frederick W Miller; Jose C Milisenda; Josep M Grau-Junyent; Albert Selva-O'Callaghan; Julie Paik; Jemima Albayda; Lisa Christopher-Stine; Thomas E Lloyd; Andrea M Corse; Andrew L Mammen
Journal:  Neurology       Date:  2019-08-21       Impact factor: 9.910

Review 7.  Autoimmune Myopathies: Updates on Evaluation and Treatment.

Authors:  Emer R McGrath; Christopher T Doughty; Anthony A Amato
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 8.  Promising and Upcoming Treatments in Myositis.

Authors:  Lauren N Smith; Julie J Paik
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

Review 9.  Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management.

Authors:  Robert W Hallowell; Julie J Paik
Journal:  Clin Exp Rheumatol       Date:  2021-03-25       Impact factor: 4.473

10.  Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients.

Authors:  Julie J Paik; Livia Casciola-Rosen; Joseph Yusup Shin; Jemima Albayda; Eleni Tiniakou; Doris G Leung; Laura Gutierrez-Alamillo; Jamie Perin; Liliana Florea; Corina Antonescu; Sherry G Leung; Grazyna Purwin; Andrew Koenig; Lisa Christopher-Stine
Journal:  Arthritis Rheumatol       Date:  2021-03-24       Impact factor: 10.995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.